Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Years ago, Stevie Cohen's group used to do that stuff and make it look big then get the little guys going crazy and buying. Then they pull their bids down and watch it fall. Sometimes they would buy big later, lower but usually disappeared. Maybe it'll be the real deal this time. I don't think SAC plays this one anymore.
Probably if Wall Street dislikes our BOD, that is a good thing. Probably distinguishes the garbage from the gourmet meal.
BSC Paladin, music to my ears. That would be so perfect (I think, in my lower level knowledge). But it sounds flat out awesome. I would love to leave WS / Big Pharma out. I would like to "get inside your head" and understand why you are ~90% certain, but no matter - I know some of the reasons already - the rest can wait. I'm patient and comfortable with Peregrine.
Like Wall Street has a high moral compass? Hmm... I think if Peregrine continues on the path they've outlined and can protect themselves from criminals, such as are found over at Wall Street, etc. they will bring such value to the field of medicine that Wall Street will be flooding them with money, hoping to catch the train before it leaves the station. I say, let's leave them in the dark until the last minute. Just a bunch of creeps anyway.
I think Warren Buffet has famously exploited the erroneous logic that the market price always reflects the true valuation. Therein lies part of the secret of wealth building, according to his philosophy and accomplishments. Thank you, Krom.
What's the industry standard?
Did you have access to the bids?
It does seem the FDA would have done their due diligence prior to approving them but I guess not?
Were they under investigation by the FDA at that time?
Really? Did you have access to the bids? Did CMS have a history of mismanagement of trials that you are aware of? I'm trying to figure out what the red flags would have been at the time PPHM chose them. Clearly unvetted by PPHM? How do you arrive at that conclusion?
It does seem the FDA would have done their due diligence prior to approving them but I guess not?
Do tell.
Do you know, weren't they FDA approved? Refresh my memory on that.
Biopharm, can you elaborate on the idea of Bavi crop science & PS targeting? Sorry if I have missed your prior posts on this - just point to one of your prior posts and I can try to follow the trail. I'm very interested in this idea and the potential relationship between Glyphosate uptake in food stocks and disease. Avoiding this in one's food intake is probably the single most important action a person can take to protect against disease.
Look here:
http://www.organic-systems.org/journal/92/JOS_Volume-9_Number-2_Nov_2014-Swanson-et-al.pdf
Race for the Cure takes on a whole new meaning... I should think there would be a race for THIS cure.
Me too, Mr Loofman. I think this is as confident a write up as I've seen in a long time and I'm very, very pleased with progress and very optimistic. Team Peregrine is executing a brilliant strategy with a very long term view into the future. I'm lovin' it. Go Team Peregrine! Best be spit shining up that rocket for a date with the moon, Mr. Loofman.
On another note, the very best to all of you this holiday season. May you and all your loved ones be healthy and happy. May those who pray, pray for the welfare of world leaders and for the safety and loving lives for children the world over.
I've figured out that the most important thing we can all do BY FAR to avoid cancer and a host of other illness is found by reading between the lines of this study:
http://www.organic-systems.org/journal/92/JOS_Volume-9_Number-2_Nov_2014-Swanson-et-al.pdf
Here's the link to the write-up
http://www.energy-executive.com/features/petroleum/199-ehrc-energy-inc
Take a look at Apple's chart and history and see how long it took them to mature as a company along with the rise in share price. I think it is much more difficult to bring an emerging biotech company to maturity, especially one with a novel & potentially disruptive technology, not to mention all the hurdles in dealing with drug trials, human illness, regulations, etc. etc.
Setting up for the fade...
That's all you got on that complaint? I'd get over it.
I think the grubby market makers are now covering and finally filled that stinking gap. So we can start going back up now or at least soon, unless something like a market correction, in which case we hold steady and market makers now have control since most weak hands already let go. JMHO.
Seems like you would have to have a BUY in there somewhere in order to have something to HOLD since the last advice was to SELL. I'd go with a BUY if you haven't already been HOLDing.
This would be the Aug, 2014 issue.
J Nucl Med. 2014; 55 (Supplement 1):1068
http://jnm.snmjournals.org/content/current
http://jnumedmtg.snmjournals.org/cgi/content/meeting_abstract/55/1_MeetingAbstracts/1068
Especially encouraging -> RT + 2aG4. Needs no partner.
OK, peace. We can disagree on Icahn. He has been successful. I still would not want that particular bull in our china closet, but peace and have a good day.
CP, look at the avg share price of shares sold via the ATM this year. I forget exactly but somewhere in the range of 1.6 and 1.5. I see that as no different than if I sold my shares at that price, I would be a participant to an agreed upon value.
You show your age and I'll show mine:
Icahn developed a reputation as a ruthless "corporate raider" after his hostile takeover of TWA in 1985.[10] The result of that takeover was Icahn systematically selling TWA's assets to repay the debt he used to purchase the company, which was described as asset stripping. In 1988, Icahn took TWA private, gaining a personal profit of $469 million, and leaving TWA with a debt of $540 million. In 1991, Icahn sold TWA's prized London routes to American Airlines for $445 million.[11]
Icahn also attempted the grand prize of U.S. Steel, launching a hostile takeover for 89% of the industrial giant for $7 billion ($15.1 billion in 2013) in late 1986. He was finally rebuffed by CEO David Roderick on January 8, 1987.[12]
http://en.wikipedia.org/wiki/Carl_Icahn
Maybe an interesting exercise would be to take a close look at each and every large position Icahn has ever taken in a company and see how many of them were strip mined and repackaged to someone else. Then compare that to Warren Buffet and see how many companies he has done that same thing to. Then see how each of them has prospered over time.
No thanks on the idea of Carl Icahn, master swindler.
That would be a bull in a china closet, IMHO. No thanks. What's he going to do, tell people in the trials to hurry up and live or die?
I tend to agree with you Bio. I don't have a financial background to be able to work out the correct valuation but until we have validation via the P3 or some other validation of the science that moves a drug closer to market in time, we are not really ready for the astronomic share pricing that some wish for. There's Avid but right now, even though its a tremendous asset, it's just helping shore up the slow burn. A partner says 'we believe in you' and that would help the confidence level as well as add some burn money to the pile and stop the ATM sales. That would be awesome and surely increase the share price but the real increases in valuation is to be found with the validation that comes from the successful P3 and continued progress with other trials towards P2, P3 and approvals. We all just need to get perspective on this and see what needs to happen before we can have those fantastic share prices. There is nothing wrong with the company or it's pipeline or its trials that is going to stand in the way of success, with the exception of criminal activity and we have been seeing that so it definitely bears watching and exposing. Great work by the way on finding the AF indictment. May he receive justice.
Thanks, so it has not been shelved. The last guidance they gave still holds - seeking a partner.
Good point. If it's been shelved, they need to let shareholders know. Probably has if it's off the website but an explanation seems to be in order either way since they took it off the site.
Well, let's say for example they come out and say:
We've added Rob Garnick to the BOD.
On partnerships, we are in talks and hope to have one (or some) completed in 2014.
On IST's, we have updated the public as soon as they update us.
On Cotara, yes, we are working on partnering Cotara.
Now what? The share price jumps to $10? Not. What more can they say on the above, truly? You want them to give out the details of partering / licensing talks? You want them to nudge the ISTs for more info and then give us the partial trial info, really?
There is also an argument to be made that if the BOD / management is aware that the share price is not aligned with their knowledge of the value of the company, they have the duty to try to correct that perception in the marketplace as a duty to shareholders.
So the question, if above is correct, is the share price in alignment with the value of the company?
What we have to go on is
1. Guidance in public PR's and conference calls, etc. They have taken the position that it is not their duty to comment on or try to effect the share price directly. (I disagree with this, personally, as I do believe it is their duty to correct a misalignment, if it exists.)
2. We have the ATM as guidance, wherein the company sells it shares to the market at pricing they mutually agree upon. Taking this into account, the existing share price is in alignment with the BOD / managements' valuation of the company.
I don't know of much else to go on as to the correct share price. They seem happy to sell shares at this price, albeit the pace has slowed now. Forward guidance then? Not much to go on there either, as they choose to refrain from forward valuation guidance. So, in order to be happy here, you must either be a speculator and/or long term shareholder with a vision of what "can be possible" and whether or not this BOD and management can deliver that vision.
I will give them this: against all odds they are managing to deliver incredible accomplishments. Saving that sabotaged trial, working with ISTs to broaden the studies of their pipelines, working towards partnering and licensing agreements, conducting multiple trials at multiple locations, managing Avid and increasing production and expansion there, hiring key employees and consultants, employing a highly prestigious law firm for guidance and protection, managing their finances without encumbering the patent portfolio, broadening the patent portfolio, picking up the pieces when Dr. Thorpe passed away and landing the accomplished Dr. Brekken to carry the torch. I've left out too many things I'm sure but these stand out. When I ask myself "can they deliver?", I say YES. YES THEY CAN DO IT. I BELIEVE THEY CAN DO IT.
But most of this falls in the category of forward pricing of the stock and the timeline is uncertain due to the complexities and unknowns of the drug trials. So really, do you think putting someone else on the BOD will correct this? Would communication correct it? Would a small partnership truly correct it? Maybe some. But it would only be a small portion of what the future can hold. My vision for the company is hugely greater than what any of these 3 things can do right now to change the share price. I've figured out that I really am going to have to be patient. Really, not a little patient but a LOT patient. Crumbs will help my spirits but they won't bring about my true vision and gaining a buck or two today still won't bring about any selling of my shares. I want it today but we are dealing with real people in real life and death struggles that will be the ultimate statement of whether or not my vision has a chance to materialize. And my prayer is "God, please let them live. Let everyone of them live. May this be the start of something truly good and beautiful in the lives of every person who has been effected by cancer. God, please help us all in this fight against cancer." That's part of my vision (viruses too!) and if it happens, the share price will follow. I don't want crumbs, I really don't want just the crumbs. I want the VISION.
Can you do something like take the P2 trial patients (n), look at the KM plot and come up with a timeline for first look by
1. extrapolating the time (CP's guestimates) to reach n patients being treated
2. the time for reaching # of events following same curve and where on the time curve it reached stat significance during P2.
No expert here as is plain to see, but seems we could make some guesses.
Thank you for this post, cjgaddy. Appreciate all your work.
One critique or observation of management after seeing these numbers - the CEO and BOD are communicating to the market place that they value the company somewhere between $1.61 - $1.95 per share. I would have thought they would value it higher than that but I guess not.
Sold 2/1/14-4/30/14: $3,017,000gr. / 1,543,383sh. = $1.95/sh.
*Total Raised via MLV Dec’12 ATM Sales thru 4-30-2014:
. . . . $68,796,000gr. / 42,848,044 = $1.61sh.
He and Sierra should get together for the Ying and Yang comedy hour. If they could last an hour.
We have quite a few talents on this board that should send their resumes to Black Rock or Barclays. Maybe be the lone dissenting voices of reason there.
I'm really very happy with the conference call and especially these words from Mr. Worsley. I love that Sunrise is off the table for partnering and I love that he called out the reasons why. If I understood everything correctly, Sunrise is expected to perform well and needs no partnering now. Additional opportunities for partnering exist in earlier phase trials. Smoke that :)
If there is an early look-in and that look-in proves to be a reason for halting the trial due to outstanding, superior results, and there is every reason to be hopeful that this will be the case, Peregrine will already be expanding their manufacturing capabilities and should be ready to ramp up production of bavi. In addition, they will have money remaining from that raised for Sunrise. Potential partners need to step up early or this first example of "going it alone" could become a pattern that defines the future of Peregrine.
I should think BMY would want to push the heck out of the Bavi + Yarvi trial, if that is possible.
One other angle might be that an institution / hedge fund / etc. can delay filing Form 13 (for VIP investor(s)) based on CA, where plaintiff divulged privileged info?
Agreed, CP. Much ado about nothing as far as using ASCO to announce a partnership. It's about a scientific research poster. But it was a good opportunity to pump and dump the share price and make it look like a disappointment. The "as usual" type of disappointment, or so they claim.
But EYEBUY, these aren't ASCO announcements - they're deals that get PR'd as usual, right? Or did I miss something. ASCO is not the forum for deals, it's for science announcements. Sure, co's might PR deals DURING this time span, but what I mean is folks shouldn't expect that ASCO is the forum where PPHM will announce a deal. They just have a poster.
ASCO is not the forum for announcing partnerships. Silly.
Sorry, wook. I didn't understand. EOM
Thank you, North40000. EOM.